Yixintang Pharmaceutical Group Co., Ltd.

SZSE:002727.SZ

21.31 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

202320222021202020192018201720162015201420132012201120102009
Operating Activities:
Net Income 549.4421,012.978917.207789.166603.318519.775422.746353.567346.439295.045239.36181.969132.762102.94584.849
Depreciation & Amortization 1,332.4081,000.641,087.76279.78273.42974.35372.88566.57351.51437.35824.73522.25519.34900
Deferred Income Tax 5.349-35.15-27.286-23.4233.40616.0734.737-4.926-12.533000000
Stock Based Compensation 3.99714.23240.40332.38900000000000
Change In Working Capital -127.677-9.723-603.930.585114.06-49.099-256.178-234.041-340.515-213.993-87.855-83.577-81.75600
Accounts Receivables 407.329-765.827-739.711-279.40740.754-31.238-16.286-272.841-359.257-94.463-140.8210000
Inventory -589.79-234.885-1,236.783-237.093-206.077-229.764-333.798-385.959-304.282-167.729-165.853-48.618-83.90700
Accounts Payables 90.4741,026.1391,399.879570.507275.977195.82989.169429.685336.511000000
Other Working Capital -35.69-35.15-27.286-23.4233.406180.66577.621151.919-36.233-46.26477.998-34.9592.15100
Other Non Cash Items 3,114.313514.124377.488124.86192.11790.743151.7036.533128.32357.80951.98537.01831.197-102.945-84.849
Operating Cash Flow 2,117.0322,497.11,791.6741,033.359982.924635.772391.156192.632185.76176.219228.225157.665101.55300
Investing Activities:
Investments In Property Plant And Equipment -253.463-348.982-391.627-280.179-206.863-156.028-142.046-146.107-194.042-158.634-145.39-103.753-97.582-139.563-26.862
Acquisitions Net -16.377-4.708-65.0883.4171.38-11.615-3.536-47.2820.0240.4410001.2130
Purchases Of Investments 0-980.518-1,976.521-5,195-3,320.856-3,015.5-250.727-390-506.728-6.93900000
Sales Maturities Of Investments 1.6921,207.2352,901.814,728.5833,022.1452,358.175517.984124.98412159.01700000
Other Investing Activites -273.222-94.733-336.905-181.548-52.652-69.298-407.28-210.505-66.475-158.6340.0640.5810.2868.2614.757
Investing Cash Flow -543.063-221.706131.669-924.727-556.846-894.266-285.605-668.91-755.221-164.749-145.326-103.172-97.296-130.09-22.105
Financing Activities:
Debt Repayment -35.551-207.946-137.109-51.054-800-514.036-850.684-532.072-83-320-186-349.525-282.875-248.96-111.8
Common Stock Issued 02.0490.104000000000000
Common Stock Repurchased -0.343-2.049-0.104000000000000
Dividends Paid -238.409-178.854-178.854-170.332-170.331-211.604-168.504-133.862-166.445-8.581-12.524-12.405-10.585-35.409-4.944
Other Financing Activities -39.466-678.611-986.797177.631596.9395.251,4621,591.284708849.049250306.954297.168469.506173.799
Financing Cash Flow -1,447.009-1,078.197-1,304.814-48.407-403.312-720.39442.812925.35458.555520.46851.476-54.9763.708185.13857.055
Other Information:
Effect Of Forex Changes On Cash 0.2090.34-0.055-0.1990.0640.521-0.070.0550-000-000
Net Change In Cash 164.0031,197.537618.47460.02622.83-978.364548.293449.127-110.906531.938134.374-0.4837.965161.94590.286
Cash At End Of Period 3,675.6342,859.481,661.9441,043.469983.443960.6131,938.9771,390.684941.4581,052.364520.425386.051386.534378.569216.624